GFAT Antibodies

Santa Cruz Biotechnology delivers a wide array of GFAT monoclonal antibodies for investigating Glutamine-Fructose-6-Phosphate Amidotransferase (GFAT) in cellular metabolism. GFAT monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GFAT is a key enzyme in the hexosamine biosynthetic pathway, which is crucial for the synthesis of glycosylated proteins and lipids. The hexosamine biosynthetic pathway plays a significant role in cellular signaling and the regulation of various physiological processes, including insulin signaling and cell growth. GFAT research is essential for understanding its involvement in metabolic disorders and diseases such as diabetes and cancer. GFAT monoclonal antibodies enable researchers to explore cellular mechanisms and pathways influenced by GFAT activity. GFAT monoclonal antibodies support detailed analysis of protein expression, localization, and interactions. Santa Cruz Biotechnology monoclonal antibodies contribute to advancing scientific knowledge and developing potential therapeutic strategies for metabolic diseases.